SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

FDA approval of FAYUVI as the first treatment for Sanfilippo syndrome Type A, along with a Priority Review Voucher, is driving attention and expectations for a commercial launch. Traders are split after the relatively muted share reaction: bulls emphasize the new revenue stream, voucher value and short interest, while skeptics point to the narrow patient population, safety and uptake considerations, and Ultragenyxs cash burn.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

A Ninth Circuit ruling that sports-event contracts are sports bets rather than federally protected swaps is drawing attention, as traders view it as a potential regulatory win for DraftKings and a setback for Kalshi-style prediction markets. Debate remains over whether the decision will materially reduce competition, with a possible Supreme Court appeal and DraftKings own prediction-market exposure leaving the longer-term impact uncertain.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

Reported insider buying by CEO Ryan Cohen, including a purchase of 1 million shares, is fueling renewed bullish interest in GameStop alongside speculation about additional buybacks. Traders are also debating whether rising call activity, borrow costs and momentum could trigger a short or gamma squeeze, though some remain cautious about the low volume and range-bound price action.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Attention centers on Helus Pharmas fully enrolled Phase 3 APPROACH trial for HLP003, with topline major-depressive-disorder data expected in Q4 2026. Traders are citing executive purchases and new CEO Michael Halstead as confidence signals, while others warn that expectations, profit-taking, and potential dilution could drive volatility.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snaps unveiling of its Specs augmented-reality glasses and Specs Intelligence AI platform, alongside enterprise integrations and partnerships, is driving attention. Traders are split between optimism that the technology could open a new computing and revenue platform and skepticism over the glasses high price, design, uncertain demand, and management credibility, with many describing the initial move as a sell-the-news reaction.

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Abeonas early commercial rollout of ZEVASKYN is driving attention, with Q2 results showing sequential revenue growth but a shortfall versus expectations after one treatment batch failed to meet the billing threshold. Traders are divided between viewing the manufacturing issue and slow treatment-center ramp as evidence of execution problems and seeing expanding centers, patient demand, and future profitability as intact catalysts.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Biohaven Pharmaceutical Holding Company Ltd

Early clinical data from Biohavens degrader programs in Graves disease and IgA nephropathy are driving attention, with traders highlighting rapid antibody reductions and signs of efficacy while viewing the platform as increasingly validated. The reaction is bullish, though some note the results remain early-stage and the broader pipeline still carries clinical and financing risk.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Attention is centered on Uniswaps Robinhood integration and its role as a liquidity layer for crypto and tokenized-asset trading, with traders linking the development to higher volume, protocol revenue, and fee-driven UNI burns. Bulls view the combination as a structural catalyst, while skeptics point to overbought technical conditions and the risk of a pullback.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is under pressure after CEO Kelly Ortberg said stabilizing 737 MAX production is taking longer than expected because of wing-production constraints, while slower 787 ramp-up and muted expectations for a near-term China order added to execution concerns. Traders are divided between bears focused on supply-chain, debt and potential SPEEA strike risks and bulls who view the selloff as an overreaction given unchanged cash-flow guidance, the large backlog and expected MAX 10 certification.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

A sharp rally and technical breakout have pushed NEAR into focus, with traders chiefly attributing the move to Zcashs outperformance and a perceived close correlation between the two tokens. The community is broadly bullish and citing NEARs AI/agent-infrastructure narrative, although some traders view the move as a liquidity pump and are positioning for a pullback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Reformation Reports Q2 2026 Results: Full Earnings Call Transcript

Reformation (NYSE:REF) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below.
Benzinga APIs provide real-time access to earnings call transcripts andread more...

Reformation Announces Second Quarter Fiscal 2026 Results

Reformation Announces Second Quarter Fiscal 2026 Results Reformation Announces Second Quarter Fiscal 2026 Results PR Newswire LOS ANGELES, Sept. 10, 2026 Net Revenue increased 24.1%Net Income grew 79.4%Adjusted EBITDA Margin expanded 320 basis points to 16.4%LOS ANGELES, Sept. 10, 2026 /PRNewswire...

Reformation to Announce Second Quarter Fiscal 2026 Results on September 10, 2026

Reformation to Announce Second Quarter Fiscal 2026 Results on September 10, 2026 Reformation to Announce Second Quarter Fiscal 2026 Results on September 10, 2026 PR Newswire LOS ANGELES, Aug. 27, 2026 LOS ANGELES, Aug. 27, 2026 /PRNewswire/ -- Reformation Inc. (NYSE:REF), the sustainable women's...

NYSE Content Update: Reformation Scores Winning Session in NYSE Debut

NYSE Content Update: Reformation Scores Winning Session in NYSE Debut NYSE Content Update: Reformation Scores Winning Session in NYSE Debut PR Newswire NEW YORK, July 31, 2026 NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, July 31, 2026 /PRNewswire/ -- The New York...

NYSE Content Update: Jersey Mike's Raises $1 Billion Ahead of NYSE Debut

NYSE Content Update: Jersey Mike's Raises $1 Billion Ahead of NYSE Debut NYSE Content Update: Jersey Mike's Raises $1 Billion Ahead of NYSE Debut PR Newswire NEW YORK, July 30, 2026 NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, July 30, 2026 /PRNewswire/ -- The New...

Reformation Inc. expects full year fiscal 2026 net revenue in the range of $602M, Adjusted EBITDA margin between 14% and 14.2%, and capital expenditures of $23M.

Reformation Inc. faces downward pressure on per-customer revenue metrics, increased debt levels utilized for shareholder dividends, and ongoing structural risks associated with potential U.S. government-imposed tariffs and trade wars.

Reformation Inc. delivered strong financial performance featuring consistent double-digit revenue growth, significant gross margin expansion, and improved Adjusted EBITDA, reflecting the enduring strength of the brand and disciplined operational execution.

Reformation, Inc. operates as a clothing brand company. It is engaged in sustainable womenswear. Its products include dresses, jeans, tops, sweaters, shoes, and accessories. The company was founded in 2009 and is headquartered in New York, NY.

Reformation Inc.

Bearish Sentiment

No more this year

One more

Two more

The Federal Reserve raised interest rates by a quarter point to a range of 3.75%-4.00% on Wednesday, its first hike since July 2023, but Fed Chair Kevin Warsh signaled the tightening cycle isn't over. How many more rate hikes do you expect by the end of 2026? Vote and explain your reasoning in the comments.

The Fed hiked rates 25bps yesterday, its first since 2023, but signaled it&#39;s not done - projections point to one or two more hikes this year. How many total hikes do you expect by year-end?

Stocktwits

The Fed hiked rates 25bps yesterday, its first since 2023, but signaled it's not done - projections point to one or two more hikes this year. How many total hikes do you expect by year-end?

Current Price	$15.31
Prev Close	$15.73
Open	$15.85
Dividend Yield	N/A
50-Day Moving Average	$14.89
Beta	0.00
Avg. Volume	452,486.46
PE Ratio	N/A

52-Week High	$17.26
52-Week Low	$12.83
Market Capitalization	$929.32M
EPS (Annual)	$35.17
Price to Book	2.47
Revenue Per Employee	$371,504.76

Feed

News

Sentiment

Earnings

Fundamentals

Info

REF Fundamentals